A new oral treatment for psoriasis and psoriatic arthritis, apremilasti is now available in Greece. Abroad he has helped many patients, famous and not.

The new drug that is in the form of a pill that is administered 2 times a day, showed in clinical trials that it improved significantly, at a rate exceeding 75%, psoriasis in patients, psoriasis in patients.

psoriasis in patients

Scientists explain that these results are not as impressive as with biological agents given by injection or under the skin., but emphasize that oral medications have minimal side effects.


but emphasize that oral medications have minimal side effects…

THE but emphasize that oral medications have minimal side effects, but emphasize that oral medications have minimal side effects, stressed that "there is an indisputable need for new drugs that can combine safety with efficacy and ease of use by filling existing therapeutic gaps. In this context, In this context.


In this context…

The marketing of the drug in the Greek market and its inclusion in the positive list of prescription drugs comes after the approval of the European Commission at the beginning of 2015.
It is a selective PDE4 inhibitor, It is a selective PDE4 inhibitor 20 years and the first oral treatment to be approved for psoriatic arthritis in recent years 15 years.
The substance has been shown to be effective in psoriasis, including difficult areas, such as the scalp and nails, as well as in psoriatic arthritis, with improvement in swollen and tender joints, with improvement in swollen and tender joints.

with improvement in swollen and tender joints

It is also important that the new drug has a favorable safety profile, It is also important that the new drug has a favorable safety profile, no preliminary diagnostic test or continuous laboratory monitoring of the patient is required.
Treatment is expected to help moderate to severe chronic plaque psoriasis in adult patients who have not responded., Treatment is expected to help moderate to severe chronic plaque psoriasis in adult patients who have not responded., or showed intolerance to another systemic treatment, including cyclosporine, of methotrexate or psoralen and ultraviolet A (PUVA).


Supermodel Kate Upton…

It can also be used as monotherapy or in combination with Disease Modifiers Antirheumatic Drugs (It can also be used as monotherapy or in combination with Disease Modifiers Antirheumatic Drugs), It can also be used as monotherapy or in combination with Disease Modifiers Antirheumatic Drugs (It can also be used as monotherapy or in combination with Disease Modifiers Antirheumatic Drugs) in adult patients who have had an inadequate response or intolerance to previous DMARD treatment.

THE Charalambos Berberidis, vice president of the Hellenic Rheumatological Society and the Professional Association of Rheumatologists of Greece stated that "psoriatic arthritis is a chronic disease and its treatment has many challenges. Now, having a different mechanism of action from existing therapies, having a different mechanism of action from existing therapies, maintaining a favorable safety profile combined with per os administration ".


Kim Kardashian…

Psoriasis and psoriatic arthritis
Psoriasis and psoriatic arthritis are two diseases associated with the deregulation of the activity of the immune system.

Psoriasis is a systemic inflammatory disease characterized by affected blade lesions on the skin.. Psoriasis is a systemic inflammatory disease characterized by affected blade lesions on the skin. 14 Psoriasis is a systemic inflammatory disease characterized by affected blade lesions on the skin. 125 millions of people around the world. millions of people around the world 80% the patients.


…millions of people around the world

In addition, millions of people around the world 30% People with psoriasis can develop psoriatic arthritis.
People with psoriasis can develop psoriatic arthritis, which is also a disease that occurs as a result of a malfunction of the immune system, which is also a disease that occurs as a result of a malfunction of the immune system 38 which is also a disease that occurs as a result of a malfunction of the immune system. It is a chronic condition characterized by pain, It is a chronic condition characterized by pain, It is a chronic condition characterized by pain, It is a chronic condition characterized by pain.

It is a chronic condition characterized by pain: It is a chronic condition characterized by pain